<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AiM</journal-id><journal-title-group><journal-title>Advances in Microbiology</journal-title></journal-title-group><issn pub-type="epub">2165-3402</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aim.2016.610075</article-id><article-id pub-id-type="publisher-id">AiM-70318</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Antagonistic Effect of Bacteria Isolated from the Digestive Tract of &lt;i&gt;Lutzomyia evansi&lt;/i&gt; against Promastigotes of &lt;i&gt;Leishmania infantum&lt;/i&gt;, Antimicrobial Activities and Susceptibility to Antibiotics
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rafael</surname><given-names>J. Vivero Gómez</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gloria</surname><given-names>E. Cadavid Restrepo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Claudia</surname><given-names>X. Moreno Herrera</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Victoria</surname><given-names>Ospina</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sandra</surname><given-names>I. Uribe</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sara</surname><given-names>M. Robledo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>PECET-Medical Research Institute, University of Antioquia, Medellin, Colombia</addr-line></aff><aff id="aff3"><addr-line>Molecular Systematics Group, National University of Colombia, Medellin, Colombia</addr-line></aff><aff id="aff1"><addr-line>Microbiodiversity and Bioprospection Research Group, Cellular and Molecular Biology Laboratory, National University of Colombia, Medellin, Colombia</addr-line></aff><pub-date pub-type="epub"><day>26</day><month>08</month><year>2016</year></pub-date><volume>06</volume><issue>10</issue><fpage>760</fpage><lpage>775</lpage><history><date date-type="received"><day>July</day>	<month>18,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>August</month>	<year>30,</year>	</date><date date-type="accepted"><day>September</day>	<month>2,</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Lutzomyia
   evansi is a phlebotomine insect endemic to Colombia’s Caribbean coast and is considered the main vector of visceral and cutaneous leishmaniasis in the region. Specific studies of the direct effects generated by bacteria in the digestive tract of the insect vectors, under Leishmania infantum using in vitro models, represent a novel alternative as a control strategy for the transmission of leishmaniasis and also provide the opportunity to detect natural products or antimicrobial peptides with different biological activities. In this study, we evaluate the leishmanicidal and antimicrobial activities of Pantoea ananatis, Ochrobactrum anthropi and Enterobacter cloacae, isolated from the digestive tract of Lutzomyia evansi and the susceptibility of these bacteria to commonly used antibiotics. The antagonistic effect of Pantoea ananatis, Ochrobactrum anthropi and Enterobacter cloacae was evaluated against six species of human pathogenic bacteria and against stationary (Metacyclic-like) and exponential promastigotes (Procyclic-like) of Leishmania infantum (BCN-GFP strain) by co-culture assays for 24 hours. The activity of the bacterial isolates on Leishmania infantum promastigotes was quantified by flow cytometry. The susceptibility of the bacterial strains to clinically used antibiotics was analyzed by antibiogram. The highest percentage of inhibition was observed against exponential promastigotes with bacterial concentrations of 10<sup>8</sup> CFU/ml of Enterobacter cloacae (77.29% &#177; 0.6%) and Pantoea ananatis (70.17% &#177; 1.1%). The extracts produced by
   three bacterial isolates showed similar biological activity (13 mm - 22 mm inhibition halos) against all tested bacteria; however, significant differences were observed with respect to gram-positive bacteria (P &lt; 0.003557). The most active antibacterial activity was displayed against the pathogenic bacteria Bacillus cereus. Ochrobactrum anthropi was the isolate with the highest number of antibiotic resistance patterns while Pantoea ananatis and Enterobacter cloacae showed greater susceptibility to the evaluated antibiotics. The growth inhibitory activity of exponential Leishmania infantum promastigotes shown by extracts of Enterobacter cloacae and Pantoea ananantis suggests that the presence of these bacteria in the vector intestine may affect the parasite development to metacyclic stages, infective to human hosts. This in turn confers said bacteria, a potential in controlling the transmission of Leishmania spp. that deserves to be studied in depth.
 
</p></abstract><kwd-group><kwd>Intestinal Microbiota</kwd><kwd> Leishmanicidal Activity</kwd><kwd> Antimicrobial Activity</kwd><kwd> Antibiotic Susceptibility</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Leishmaniasis remains as a public health problem worldwide due to its morbidity and geographical distribution [<xref ref-type="bibr" rid="scirp.70318-ref1">1</xref>] . Transmission of the disease is complex and involves not only the participation of different species of Leishmania parasites but also sandflies vector insects [<xref ref-type="bibr" rid="scirp.70318-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref3">3</xref>] and mammalian species that serve as reservoirs for the parasite. The infection in humans generates various clinical manifestations, being visceral leishmaniais (VL) one of the clinical forms with greater impact in the Americas specifically in countries like Colombia, Brazil and Venezuela for the possibility of causing the death of patients if not diagnosed and treated early [<xref ref-type="bibr" rid="scirp.70318-ref4">4</xref>] .</p><p>Currently, the VL presents difficulties associated with treatment, diagnostic tests and surveillance and control strategies of insect vectors [<xref ref-type="bibr" rid="scirp.70318-ref5">5</xref>] . This problem is attributed mainly to the emergence of drug-resistant strains of the L. infantum parasite, as well as the ubiquity and adaptability of vector insects, Lu. longipalpis, and Lu. evansi, and the existence of different eco-epidemiological settings where transmission can occur [<xref ref-type="bibr" rid="scirp.70318-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref7">7</xref>] . Therefore, it is necessary to explore alternatives aimed at interrupting the transmission of the infection and thereby reduce the impact of leishmaniasis in public health [<xref ref-type="bibr" rid="scirp.70318-ref8">8</xref>] . An alternative option to the chemical control of vectors or to the synthetic generation of vaccines and treatments is to understand the “intestinal microbiota” of sandflies vectors [<xref ref-type="bibr" rid="scirp.70318-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref10">10</xref>] .</p><p>From a holistic point of view, it is suggested to integrate the isolation of bacterial communities and the study of the action or activity of bacteria by generating secondary metabolites and bacterial peptides that can impact directly (antileishmanial activity) or indirectly (immune system) the development of Leishmania parasites, being decisive in the modulation of the transmission or vector competence of Lutzomyia spp [<xref ref-type="bibr" rid="scirp.70318-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref12">12</xref>] . There are several studies on intestinal microbiota in sandflies aimed at finding molecules with antileishmanial activity. Among these, the study of lytic effects generated in L. chagasi (syn L. infantum) by its interaction with Serratia marcescens [<xref ref-type="bibr" rid="scirp.70318-ref13">13</xref>] , the variability of molecules like defensins in Phlebotomus duboscqi induced by changes in the microbiota [<xref ref-type="bibr" rid="scirp.70318-ref14">14</xref>] , the generation of reactive oxygen species mediated by S. marcescens against L. mexicana in the digestive tract of Lu. Longipalpis [<xref ref-type="bibr" rid="scirp.70318-ref15">15</xref>] and most recently, the in vitro activity of Pseudozyma sp., Asaia sp., and Ochrobactrum intermedium against the development of promastigotes of L. Mexicana [<xref ref-type="bibr" rid="scirp.70318-ref16">16</xref>] . In Colombia, there are not known studies that have explored the usefulness of the intestinal microbiota of insects that transmit Leishmania spp.</p><p>Lu. evansi, is a vector recognized species for transmitting parasites that generate cutaneous and VL in rural and urban environments of the Caribbean coast of Colombia [<xref ref-type="bibr" rid="scirp.70318-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref18">18</xref>] . Its abundance and epidemiological importance made it an attractive biological model for the preliminary study of the microbiota using a culture dependent approach under aerobic conditions. This strategy allowed the isolation of bacterial strains P. ananatis, O. anthropi and E. cloacae, arousing interest either by being dominant in the digestive tract of Lu. evansi (E. cloacae), by being symbionts (P. ananatis) or by their reports on antitrypanosomal activity (Ochrobactrum sp.) [<xref ref-type="bibr" rid="scirp.70318-ref16">16</xref>] . Therefore, this study aimed to evaluate the leishmanicidal and antibacterial activity of extracts and whole bacteria (P. ananatis, O. anthropi and E. cloacae), isolated from the digestive tract of Lu. evansi and their susceptibility to antibiotics.</p></sec><sec id="s2"><title>2. Methodology</title><sec id="s2_1"><title>2.1. Ethics Statement</title><p>Sand fly collection was performed in accordance with the parameters of Colombian decree number 1376, which regulates specimen collection of biologically diverse wild species for non-commercial research. No specific permits were required for this study. The sand flies were collected on private property and permission was received from landowners prior to sampling.</p></sec><sec id="s2_2"><title>2.2. Identification of Bacterial Isolates and Estimate Cell Concentration</title><p>P. ananatis, O. anthropi and E. cloacae all Gram negative strains were isolated from the digestive tract of adults and immatures from natural populations of Lu. evansi, associated with a peri-urban biotype from the municipality of Ovejas (Sucre department, Caribbean coast of Colombia), classified as a tropical dry forest ecosystem. The adult specimens were collected using Shannon-type extra-domiciliary white light traps that remained active between 18:00 h and 22:00 h. Prior to gut dissection, adult specimens were washed with 50 μL of 1X PBS and Tween 20, centrifuged at 3000 g for 5 minutes, and submerged in a 70% ethanol wash for one minute to remove excess microvilli, dust and exogenous bacteria.</p><p>The guts of adult Lu. evansi specimens were removed aseptically with sterile stilettos under a stereoscope in 1X PBS buffer. Isolates were cultured under aerobic conditions (33˚C for 24 and 48 hours) by surface plating intestinal homogenates on Luria-Bertani (LB) agar (Merck). The selected isolates were purified, characterized by macro and microscopic appareance of the colony, Gram stained (Figures 1(a)-(c)) and molecularly by analyzing the spacer region (ITS) between the 23S and 16S ribosomal gene, the 16S rRNA and (<xref ref-type="fig" rid="fig1">Figure 1</xref>(d)) gyrB genes partial nucleotide sequences. Estimated concentrations of 10<sup>7</sup> CFU/ml and 10<sup>8</sup> CFU/ml were calculated to challenge the isolates in the in vitro activity test against promastigotes of L. infantum. The cell concentration of bacteria was estimated with commercial McFarland turbidity standard pattern (BBL McFarland Turbidity Standard No. 0.5).</p></sec><sec id="s2_3"><title>2.3. Reactivation of Leishmania infantum Fluorescent Promastigotes, Fluorescence Emission Estimation and Calculation of Cell Concentration</title><p>The BCN-GFP strain of L. infantum transfected with green fluorescent protein was thawed and planted in biphasic modified Novy, Nicolle and McNeal (NNN) medium for growth of promastigotes, verifying their viability by observation with a fluorescence inverted microscope (Nikon eclipse TS100) [<xref ref-type="bibr" rid="scirp.70318-ref19">19</xref>] . GFP-expressing promastigotes were analyzed flow cytometrically in 10,000 gated events and the numeric data were processed by using WinMDI software. L. infantum promastigotes were incubated at 26˚C, performing successive sub-cultures to obtain parasites with 98% of fluorescence, which allow estimating the action of bacterial isolates in vitro by flow cytometry.</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Colony morphology (left panel), Gram stain (right panel) of the strains P. ananatis (a); E. cloacae (b); O. anthropi; (c) isolated from the gut of Lu. evansi and NJ dendrogram (d) of partial nucleotide sequences of 16S gene, illustrating the taxonomic confirmation of the bacterial isolates</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2270807x2.png"/></fig></sec><sec id="s2_4"><title>2.4. In Vitro Antileishmanial Activity Assay of Bacterial against Stationary and Exponential Promastigotes of L. infantum</title><p>Metacyclic-like (6 days of culture, stationary) and procyclic-like (3 days of culture, exponential) promastigotes of L. infantum were centrifuged at 1500 g for 10 minutes, washed twice with sterile PBS buffer for carbohydrate removal and then re suspended in single phase RPMI liquid culture medium without antibiotic at a final concentration of 3 &#215; 10<sup>6</sup> parasites/ml for each co-culture and activity assay.</p><p>Cultures of P. ananatis, O. anthropi and E. cloacae grown in liquid LB medium (Merk) to 10<sup>8</sup> CFU/ml and 10<sup>7</sup> CFU/ml were obtained. These concentrations have been the most used in studies that evaluate the leishmanicidal activity of bacteria obtained from the digestive tract of insects [<xref ref-type="bibr" rid="scirp.70318-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref16">16</xref>] . The cell pellet (concentrated by centrifugation at 6500 g for 5 minutes) was washed twice with sterile PBS buffer. Bacteria were re-suspended in PBS to a final concentration of 10<sup>7</sup> CFU/ml and incubated for 24 hours at 27˚C with metacyclic-like or procyclic-like L. infantum promastigotes in RPMI. The trials were independent for each strain and in triplicate for each stage of development of the parasite. Cell viability controls consisted of PBS with promastigotes and the three bacterial strains re-suspended in PBS independently.</p></sec><sec id="s2_5"><title>2.5. Quantification of the Bacterial Isolates Activity on L. infantum Promastigotes</title><p>The action of bacterial isolates on the viability of L. infantum promastigotes were determined by flow cytometry on a Cytomics FC 500MPL using an argon laser at 488nm of excitation and 525nm of emission, counting at least 10,000 events to calculate the number of fluorescent promastigotes. The acquired data was analyzed using the CXP (Beckman Coulter, Fullerton, CA, USA) software.</p></sec><sec id="s2_6"><title>2.6. Evaluation of Antibacterial Activity from Extracts Secreted by P. ananatis, O. anthropi and E. cloacae</title><p>Production and evaluation of secondary metabolites secreted was performed following the method previously described [<xref ref-type="bibr" rid="scirp.70318-ref20">20</xref>] . An Erlenmeyer containing 50 ml of 2% LB broth (w/v), 2% Amberlite resin XAD-16 (W/V), was inoculated with 0.5 ml of each strain culture and grown overnight [<xref ref-type="bibr" rid="scirp.70318-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref21">21</xref>] . This Amberlite, allows adsorption of organic substances of small and medium molecular weight in aqueous solutions. This is a macroreticular resin nonionic that absorbs and releases substances through hydrophobic and polar interactions [<xref ref-type="bibr" rid="scirp.70318-ref22">22</xref>] . These resins have been used successfully in the identification and characterization of antibiotics [<xref ref-type="bibr" rid="scirp.70318-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref21">21</xref>] and other secondary metabolites.</p><p>After seven days of incubation at 30˚C and 180 rpm, the resin was decanted from the culture medium and washed with distilled water and the absorbed products were eluted with 40 ml of 100% methanol for 30 minutes [<xref ref-type="bibr" rid="scirp.70318-ref23">23</xref>] . Each extract was then concentrated to 1.5 ml in a rotating evaporator at 40˚C (Heidolph Efficient Rotary Evaporator Laborota 4001).</p><p>The bacteria used were reference strains: Escherichia coli, Enterococcus faecalis, Bacillus cereus, Pseudomonas aeruginosa, S. marcescens and Staphylococcus aureus subsp. aureus (<xref ref-type="table" rid="table2">Table 2</xref>). Psychrobacter sp. CP25 isolates were used as controls (positive control from Microbiop reference strain collection, National University of Colombia), Methanol (negative control) and the antibiotic chloramphenicol (10 ug/ml, positive control).</p><p>Diffusion test in agar was used [<xref ref-type="bibr" rid="scirp.70318-ref24">24</xref>] . Sterile Whatman No.1 filter paper discs, 6 mm diameter, were impregnated with 10, 20 and 50 ul of each extract and placed on the surface of Petri dishes containing Mueller-Hinton agar (Becton Dickinson), previously inoculated with a liquid culture of the target strains at a concentration of 1.2 &#215; 10<sup>8</sup> CFU/ml (absorbance 600 nm = 0.1). The plates were incubated at 37˚C for 18 hours and the diameter of the growth inhibition halo around each disk was measured. Determination of the antibacterial activity was performed following the procedure described by Bauer et al. 1966 and amended by the Clinical and Laboratory Standards Institute [<xref ref-type="bibr" rid="scirp.70318-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref26">26</xref>] . The antibacterial activity assays were performed in duplicate in two independent experiments.</p></sec><sec id="s2_7"><title>2.7. Antibiotic Susceptibility Test</title><p>The antibiotic susceptibility tests for the bacterial isolates (P. ananatis, O. anthropi and E. cloacae), were developed with Mueller Hilton agar plates (Bckton Dickinson). An inoculum of 10<sup>8</sup> CFU/ml of each bacterial isolate was used (0.5 units on the McFarland scale, McFarland Turbidity Standard BBL). All isolates were tested against 14 different antibiotics of known concentration classified as follows: Rifampicin (RD 5; Oxoid, 5 ug), Tetracycline (Te 30, Valtek, 30 mcg), Gentamicin (CN120; Oxoid; 120 ug - 10 ug ); Penicillin (P 30; Comprolab; 30 FMU), Chloramphenicol (C 30; Oxoid, 30 ug), Sulbactam Cefopeazone (SFC 105; Oxoid, 105 ug), Cefepime (CEP; Oxoid, 30 ug); Cefoperazone (PIC; Oxoid, 75 ug), Cefuroxime (CXM, Oxoid; 30 ug), Cephazolin (KZ; Oxoid, 30 ug), Ceftriaxone (CRO; Oxoid, 30 ug), Cefoxitin (FOX; Oxoid, 30 ug) Ceftazidime (CAZ; Oxoid, 30 ug). The plates were incubated at 30˚C for 24 hours and the bacterial growth inhibition halos were measured by the diameter in mm. The percentage inhibition was calculated with reference to the measurement of the diameter of the inhibition zone, established for gram positive and gram negative bacteria (M100-S25 protocol- Performance Standards for Antimicrobial Susceptibility Testing).</p></sec><sec id="s2_8"><title>2.8. Data Analysis</title><p>Statistical analysis of the antibacterial activity was estimated by a two-way ANOVA with the GraphPad Prism version 4.0 program using the extracts and targeted pathogenic bacteria as factors. Based on the diameter of the antibiotics inhibition halos (growth inhibition), bacteria were categorized as susceptibility, moderately susceptibility, highly susceptibility and resistant according to the M100-S25 protocol (Performance Standards for Antimicrobial Susceptibility Testing).</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. In Vitro Bacterial Test with Procyclic and Metacyclic Promastigotes</title><p>The co-culture of the three bacterial isolates with promastigotes of L. infantum caused inhibition of procyclic-like but not metacyclic-like promastigotes. A greater impact on the inhibition percentage of the promastigotes using the bacterial cell concentration of 1 - 2 &#215; 10<sup>8</sup> CFU/ml (<xref ref-type="table" rid="table1">Table 1</xref>) was observed. The standard deviation calculated for triplicate assays of co-culturing bacteria and promastigotes was low SD = 0.5 and 5.3, respectively, indicating that the experimental design is robust.</p><p>A greater impact of cell concentration of 1 - 2 &#215; 10<sup>8</sup> CFU/ml of E. cloacae and P. ananatis on the percent inhibition of procyclic-like parasites is further noted, with values of 70.17 &#177; 1.1 and 77.29 &#177; 0.6 respectively (<xref ref-type="table" rid="table1">Table 1</xref>), whereas E. cloacae also significantly altered the development of procyclic-like promastigotes with bacterial concentrations of 1 - 2 &#215; 10<sup>7</sup> CFU/ml (<xref ref-type="table" rid="table1">Table 1</xref>). O. anthropi had the lowest inhibitory activity on procyclic-like (62.33 &#177; 2.0; 38.13 &#177; 1.4) and metacyclic-like promastigotes (32.95 &#177; 5.3; 36.81 &#177; 3.2), with respect to the other two isolates analyzed. P. ananatis was the only bacterial isolate that presented inhibitory activity of 50.01% of metacyclic- like promastigotes.</p></sec><sec id="s3_2"><title>3.2. Antimicrobial Activity Test of Crude Methanolic Extracts</title><p>The three extracts produced by O. anthropi, P. ananatis and E. cloacae exhibited similar antimicrobial activity patterns against all bacteria tested, with inhibition zones between 13 mm and 22 mm (<xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>). Highly significant differences between the inhibition zones associated with gram-positive bacteria used were found (P &lt; 0.003557). The species most susceptibility to the extracts produced by the isolates from the digestive tract of Lu. evansi was B. cereus, with inhibition halos of 22 mm with others less susceptibility to the extracts activity like E. coli and E. faecalis, with inhibition halos between 13 mm and 15 mm. <xref ref-type="fig" rid="fig2">Figure 2</xref>(a) shows the antibacterial activity of the E. cloacae extract (more active) with the clinical isolate B. cereus.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> In vitro activity of three bacterial isolates from the gut of Lu. evansi against procyclic and metacyclic promastigotes of Leishmania infantum</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Cell Concentration</th><th align="center" valign="middle"  colspan="2"  >O. anthropi</th><th align="center" valign="middle"  colspan="2"  >P. ananatis</th><th align="center" valign="middle"  colspan="2"  >E. cloacae</th></tr></thead><tr><td align="center" valign="middle" >Inhibition % MP</td><td align="center" valign="middle" >Inhibition % PP</td><td align="center" valign="middle" >Inhibition % MP</td><td align="center" valign="middle" >Inhibition % PP</td><td align="center" valign="middle" >Inhibition % MP</td><td align="center" valign="middle" >Inhibition % PP</td></tr><tr><td align="center" valign="middle" >1 - 2 &#215; 10<sup>7 </sup>CFU/ml<sup> </sup></td><td align="center" valign="middle" >36.81 &#177; 3.2</td><td align="center" valign="middle" >38.13 &#177; 1.4</td><td align="center" valign="middle" >44.46 &#177; 3.2</td><td align="center" valign="middle" >66.41 &#177; 0.5</td><td align="center" valign="middle" >38.12 &#177; 0.5</td><td align="center" valign="middle" >71.04 &#177; 1.2</td></tr><tr><td align="center" valign="middle" >1 - 2 &#215; 10<sup>8 </sup>CFU/ml<sup> </sup></td><td align="center" valign="middle" >32.95 &#177; 5.3</td><td align="center" valign="middle" >62.33 &#177; 2.0</td><td align="center" valign="middle" >50.01 &#177; 1.3</td><td align="center" valign="middle" >70.17 &#177; 1.1</td><td align="center" valign="middle" >48.73 &#177; 1.5</td><td align="center" valign="middle" >77.29 &#177; 0.6</td></tr></tbody></table></table-wrap><p>The data represents the average value (X) &#177; standard deviation (SD) of two experiments each in triplicate. Symbols: CFU/ml colony forming units per milliliter; % Percentage; &#177; standard deviation; MP metacyclic promastigotes of Leishmania infantum; PP procyclic promastigotes of Leishmania infantum. Note: Number of parasites in each trial = 3 &#215; 10<sup>6</sup> parasites/ml.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Antibacterial activity of extracts produced by strains O. anthropi, E. cloacae and P. ananatis isolated from the gut of Lu. evansi</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Bacterial Group</th><th align="center" valign="middle"  colspan="6"  >Target microorganism/ Inhibition halo (mm)*</th></tr></thead><tr><td align="center" valign="middle"  colspan="4"  >Gram negative</td><td align="center" valign="middle"  colspan="2"  >Gram positive</td></tr><tr><td align="center" valign="middle" >Strain tested (Extract source)</td><td align="center" valign="middle" >E. coli (ATCC&#174; 8739™)</td><td align="center" valign="middle" >P. aeruginosa (ATCC&#174; 9027™)</td><td align="center" valign="middle" >S. marcescens (Clinical isolate)</td><td align="center" valign="middle" >B.cereus (Clinical isolate)</td><td align="center" valign="middle" >E. faecalis (ATCC&#174; 51299™)</td><td align="center" valign="middle" >S. aureus subsp. aureus (ATCC&#174; 29213™)</td></tr><tr><td align="center" valign="middle" >O. anthropi</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >15.5</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >19</td></tr><tr><td align="center" valign="middle" >E. cloacae</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >17.5</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >19</td></tr><tr><td align="center" valign="middle" >P. ananatis</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >17</td></tr><tr><td align="center" valign="middle" >Psychrobacter sp. C+</td><td align="center" valign="middle" >18.5</td><td align="center" valign="middle" >13.5</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >13.5</td></tr><tr><td align="center" valign="middle" >Methanol C−</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >8.5</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Chloramphenicol C+</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >34.5</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >33.5</td></tr></tbody></table></table-wrap><p>C+: positive control; C−: negative control; mm: diameter of the inhibition zones, average of the replicates per sample.</p><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Agar diffusion assay of the antibacterial activity of the extracts produced by P. ananatis (140), E. cloacae (139), O. anthropi (102): (a) antibacterial activity against B. cereus; (b) antibacterial activity against E. faecalis; (c) antibacterial activity against E. coli; (d) antibacterial activity against P. aeruginosa; and. antibacterial activity against S. aureus subsp. aureus; F. antibacterial activity against S. marcescens; C− = methanol; C+ = Chloramphenicol; CP25 = Psychrobacter</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2270807x3.png"/></fig></sec><sec id="s3_3"><title>3.3. Antibiotic Susceptibility Test</title><p>The E. cloacae and P. ananatis isolates showed resistance to penicillin and rifampicin, while O. anthropi presented antibiotic resistance to Cephazolin and Cefoxitin (<xref ref-type="table" rid="table3">Table 3</xref>). Additionally, O. anthropi presented a greater number of resistance patterns to anti- biotics, being resistant to penicillin, sulbactam, cefopeazone, cefuroxime, cephazolin, ceftriaxone, cefoxitin and ceftazidime (<xref ref-type="table" rid="table3">Table 3</xref>). E. cloacae and P. ananatis had higher susceptibility, mainly with Beta-lactams, cephalosporins, chloramphenicol and whereas O. anthropi only presented high susceptibility with tetracyclines and aminoglycosides (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec></sec><sec id="s4"><title>4. Discussions</title><p>The bacterial isolates P. ananatis, O. anthropi and E. cloacae, obtained from the intestinal microbiota of Lu. evansi assessed in this study exhibited differential activity against L. infantum as well as a differential susceptibility to antibiotics and against clinical isolates. The high inhibition percentage (72.29%) is generated by E. cloacae against procyclic-like promastigotes of L. infantum, when co-cultured under in vitro conditions is emphasized. This is the first study demonstrating the in vitro activity of E. cloacae against promastigotes of Leishmania, from studies that recognize its importance in the vector competence of some insects [<xref ref-type="bibr" rid="scirp.70318-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref27">27</xref>] . It is suggested that the action of E. cloacae can be derived from the expression of peptides or molecules with lytic activity on the surface of prokaryotes, by the action of enterococcal cytolysins (hemolysin) [<xref ref-type="bibr" rid="scirp.70318-ref28">28</xref>] . However, this hypothesis needs further studies.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Antibiotic sensitivity patterns of the strains O. anthropi, E. cloacae and P. ananatis isolated from the gut of Lu. evansi</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Classification</th><th align="center" valign="middle"  rowspan="2"  >Antibiotic</th><th align="center" valign="middle"  colspan="3"  >Bacterial isolates (10<sup>8</sup> CFU/ml)</th></tr></thead><tr><td align="center" valign="middle" >E. cloacae</td><td align="center" valign="middle" >P. ananatis</td><td align="center" valign="middle" >O. anthropi</td></tr><tr><td align="center" valign="middle" >Rifamycins</td><td align="center" valign="middle" >Rifampicin (RD)</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" ><sup>++ </sup></td></tr><tr><td align="center" valign="middle" >Tetracyclines</td><td align="center" valign="middle" >Tetracyclin (Te)</td><td align="center" valign="middle" ><sup>++ </sup></td><td align="center" valign="middle" ><sup>++ </sup></td><td align="center" valign="middle" ><sup>+++ </sup></td></tr><tr><td align="center" valign="middle" >Aminoglycosides</td><td align="center" valign="middle" >Gentamicin (CN120)</td><td align="center" valign="middle" ><sup>++ </sup></td><td align="center" valign="middle" ><sup>++ </sup></td><td align="center" valign="middle" ><sup>+++ </sup></td></tr><tr><td align="center" valign="middle" >Beta-Lactams</td><td align="center" valign="middle" >Penicillin (P)</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >R</td></tr><tr><td align="center" valign="middle" >Chloramphenicol</td><td align="center" valign="middle" >Chloramphenicol (C)</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+ </sup></td></tr><tr><td align="center" valign="middle" >Cephalosporins</td><td align="center" valign="middle" >Sulbactam Cefopeazone (SFC)</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" >R</td></tr><tr><td align="center" valign="middle" >Cephalosporins</td><td align="center" valign="middle" >Cefepime (CEP)</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+ </sup></td></tr><tr><td align="center" valign="middle" >Cephalosporins</td><td align="center" valign="middle" >Cefoperazone (CFP)</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+ </sup></td></tr><tr><td align="center" valign="middle" >Cephalosporins</td><td align="center" valign="middle" >Cefuroxime (CXM)</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>++ </sup></td><td align="center" valign="middle" >R</td></tr><tr><td align="center" valign="middle" >Cephalosporins</td><td align="center" valign="middle" >Cephazolin (KZ)</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" >R</td></tr><tr><td align="center" valign="middle" >Cephalosporins</td><td align="center" valign="middle" >Ceftriaxone (CRO)</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" >R</td></tr><tr><td align="center" valign="middle" >Cephalosporins</td><td align="center" valign="middle" >Cefoxitin (FOX)</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" >R</td></tr><tr><td align="center" valign="middle" >Cephalosporins</td><td align="center" valign="middle" >Ceftazidime (CAZ)</td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" ><sup>+++ </sup></td><td align="center" valign="middle" >R</td></tr></tbody></table></table-wrap><p>Symbols: R resistant (full growth); <sup>+</sup>Sensitive (Halo 10 - 17 mm); <sup>++</sup>Moderately sensitive (Halo 18 - 27mm); <sup>+++</sup>Highly sensitive (Halo of 28 - 37 mm).</p><p>In this sense, some studies have reported that the protective response of L. infantum procyclic promastigotes associated with the generation of glycoconjugates (proteophos- phoglycans, acid phosphatase, lipophosphoglycans, metalloproteins) [<xref ref-type="bibr" rid="scirp.70318-ref29">29</xref>] , is not suffi- cient for protection against enzymes or highly pathogenic bacterial peptides expressed by E. cloacae. According to the literature, in this state lifecycle (24 - 48 hrs), procyclical promastigotes of L. infantum present a lower degree of specialization and adaptation with respect to the metacyclic promastigotes (infective stage), which produce stronger enzymes such as chitinases that may even degrade the insects stomodeal valve and have a defence system resistant to mammalian complement factors and greater mobility [<xref ref-type="bibr" rid="scirp.70318-ref30">30</xref>] . The in vitro activity of E. cloacae on procyclic-like promastigotes of Leishmania is consistent and can justify their use in paratrasgenesis to express antitrypanosomal peptides, because other reports state that the bacteria also block the development of other parasites as Plasmodium falciparum in Anopheles gambiae and the sporogonic development of P. vivax in An. albimanus [<xref ref-type="bibr" rid="scirp.70318-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref31">31</xref>] .</p><p>Similar to E. cloacae, the symbiont P. ananatis showed a significant activity over the survival (70.17%) of the procyclic promastigotes of L. infantum. P. ananatis only has reported entomopathogenic activity for other insects [<xref ref-type="bibr" rid="scirp.70318-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref33">33</xref>] . These aspects are intere- sting because these bacteria could be used to disrupt the life cycle of sandflies and the transmission of Leishmania spp, by the rapid spread and adaptation of these arthropods [<xref ref-type="bibr" rid="scirp.70318-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref34">34</xref>] , as previously described in a study in which P. agglomerans (family Entero- bacteriaceae) was genetically modified, to express and secrete two anti-plasmodium effectors proteins (pelB, hly) in infected mosquitoes [<xref ref-type="bibr" rid="scirp.70318-ref35">35</xref>] .</p><p>The dissemination of P. ananatis symbiont to organs or complex structures of insects suggests that it is a specialized bacterium [<xref ref-type="bibr" rid="scirp.70318-ref33">33</xref>] , which is supported by its pan-genome that incorporates a large number of protein encoding genes that enable P. ananatis to colonize, persist and secrete a wide range of peptides [<xref ref-type="bibr" rid="scirp.70318-ref34">34</xref>] . This can also be related to the better activity over the survival of metacyclic promastigotes (50.01%) compared to E. cloacae and O. anthropi. O. anthropi had lower activity against metacyclic (32.95%) and procyclic promastigotes (62.33%). Unlike our results, the activity of other Ochro- bactrum species (O. intermedium, Ochrobactrum sp., AK strain) presented greater impact (~90%) on the survival of L. mexicana promastigotes in co-infection trials with Lu. longipalpis and in vitro assays [<xref ref-type="bibr" rid="scirp.70318-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref36">36</xref>] .</p><p>The crude methanolic extracts exhibited similar antimicrobial activity patterns against target bacteria, with a difference appreciated mainly against the growth of B. cereus (22 mm), suggesting that the isolates O. anthropi, E. cloacae and P. ananatis are important sources of promising antimicrobial compounds with a wide biological activity spectrum. In this sense these compounds or secreted peptides, can provide selective advantages to these bacteria in different environmental niches (including the digestive tract of sandflies) and be important for colonization, providing virulence factors and defence systems to keep its niche or prevent invasion from other bacterial strains [<xref ref-type="bibr" rid="scirp.70318-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref37">37</xref>] .</p><p>Gram negative bacteria, such as those used in this study, currently have six types of protein secretion systems reported (T1SS to T6SS) associated with bacterial compete- tion [<xref ref-type="bibr" rid="scirp.70318-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref39">39</xref>] . Among these systems, T6SS has a role in cytotoxicity, biofilm formation, antimicrobial peptide transport and interaction with host cells. This system has recently been described for P. ananatis, being responsible for their potential virulence and antimicrobial activity [<xref ref-type="bibr" rid="scirp.70318-ref38">38</xref>] .</p><p>Some members of the Enterobacteriaceae family are known to produce bacteriocins (3% to 26%) such as enterocins, colicins and antimicrobial lipopeptides produced by different species of Enterobacter, with great biopharmaceutical potential [<xref ref-type="bibr" rid="scirp.70318-ref40">40</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref41">41</xref>] suggesting that bacteriocins are produced by these bacteria as part of their defense mechanism to survive complex environments such as the digestive tract of different kinds of insect vectors (Lutzomyia, Phlebotomus, Anopheles, Aedes) where E. cloacae is a dominant taxonomic unit [<xref ref-type="bibr" rid="scirp.70318-ref32">32</xref>] .</p><p>Additionally, O. anthropi, which also exhibits antimicrobial activity against Gram positive and Gram negative bacteria, is of great interest for bioremediation and for their ability to degrade organophosphates [<xref ref-type="bibr" rid="scirp.70318-ref42">42</xref>] . In this sense, knowledge on antimicrobial peptides secreted by O. anthropi is interesting because this bacterium can transfer pesticide resistance factors to sandflies or simply remove pesticides by degradation [<xref ref-type="bibr" rid="scirp.70318-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref43">43</xref>] . O. anthropi secretes detoxification enzymes, reactive oxygen species and nucleo- sides of great interest for their anti-tumoral, antiviral, antibiotic and antiparasitic activity [<xref ref-type="bibr" rid="scirp.70318-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref45">45</xref>] .</p><p>Few reports inform about the susceptibility of antibacterial compounds from O. anthropi. In our study, this isolate was resistant to most cephalosporins and penicillins, but susceptible to rifampicin, chloramphenicol, some cephalosporins (cefepime, cefoperazone), tetracycline and gentamicin. The latter two antibiotics were the most active on O. anthropi. Our results are consistent with other studies reporting multi-re- sistance patterns present in O. anthropi [<xref ref-type="bibr" rid="scirp.70318-ref46">46</xref>] [<xref ref-type="bibr" rid="scirp.70318-ref47">47</xref>] . However some strains of O. anthropi exhibit resistance patterns to cefepime [<xref ref-type="bibr" rid="scirp.70318-ref48">48</xref>] and only in few cases they are susceptibility to cefoperazone [<xref ref-type="bibr" rid="scirp.70318-ref49">49</xref>] .</p><p>Unlike O. Anthropi, the E. cloacae and P. ananatis isolates exhibited fewer resistance patterns to the antibiotics tested, and agreed in their response to penicillin and rifampicin, while P. ananatis was also resistant to cephazolin and cefoxitin. Both bacteria are reported as multiresistant for its environmental ubiquity and invasion of different hosts including soils, plants, animals and insects [<xref ref-type="bibr" rid="scirp.70318-ref50">50</xref>] . The greatest susceptibility pattern of these two isolated correspond to cephalosporins, although some reports indicate their resistance to cefuroxime [<xref ref-type="bibr" rid="scirp.70318-ref50">50</xref>] . Although bacterial resitencia is analyzed in vitro in this study, the result may indicate competitive factors and/or growth of bacteria in the gut, which may favour the development or block Leishmania promastigotes.</p><p>The antibiotic susceptibility tests of the intestinal microbiota of insect vectors are important for co-infection based assays with parasites or viruses, in order to evaluate drugs, vaccines or to determine the autonomous vector competence of the insect. In this sense, to remove or modulate the resident intestinal microbiota depends on the resistance state to certain antibiotics, and allows to access the functional relationships between gut microbiota and their hosts.</p><p>The ability of E. cloacae and P. ananatis to inhibit the growth of procyclic-like promastigotes of L infantum in co-culture and the similar susceptibility patterns shown by O. anthropic, suggest that these isolates are promising for future control strategies aimed at evaluating the parasite load in Lutzomyia species when exposed to E. cloacae and P. ananatis, in order to provide new ways to reduce the transmission of leishma- niasis.</p></sec><sec id="s5"><title>Acknowledgements</title><p>Acknowledge the support by Luisa Montoya (Microbiodiversity and Bioprospection Research Group, Cellular and Molecular Biology Laboratory, National University of Colombia). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.</p></sec><sec id="s6"><title>Authors’ Contributions</title><p>CXMH, GECR and SUS: Designed the study, analyzed the data and contributed to write the manuscript. RJV, SR: Designed the study, performed the experiments, analyzed the data and contributed to write the manuscript. VO: Performed the experiments and analyzed the data.</p></sec><sec id="s7"><title>Funding</title><p>Administrative Department of Science, Technology and Innovation-COLCIENCIAS (Grant CT-695-2014 and Doctoral studies 528-2011); Grupo de Microbiodiversidad y Bioprospecci&#243;n and Grupo de Investigaci&#243;n en Sistem&#225;tica Molecular, Universidad Nacional de Colombia, Sede Medell&#237;n.</p></sec><sec id="s8"><title>Conflict of Interest</title><p>There is no conflict of interest from other co-others in the publication of this manuscript in this journal. All the co-others have contributed in the preparation of the manuscript up to the submission stage.</p></sec><sec id="s9"><title>Cite this paper</title><p>G&#243;mez, R.J.V., Restrepo, G.E.C., Herrera, C.X.M., Ospina, V., Uribe, S.I. and Robledo, S.M. (2016) Antagonistic Effect of Bacteria Isolated from the Digestive Tract of Lutzomyia evansi against Pro- mastigotes of Leishmania infantum, Antimicrobial Activities and Susceptibility to Antibiotics. Advances in Microbiology, 6, 760-775. http://dx.doi.org/10.4236/aim.2016.610075</p></sec></body><back><ref-list><title>References</title><ref id="scirp.70318-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Alvar, J., Velez, I., Bern, C., et al. (2012) Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE, 7, e35671. http://dx.doi.org/10.1371/journal.pone.0035671</mixed-citation></ref><ref id="scirp.70318-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Amora, S., Bevilaqua, C., Feijo, F., Alves, N. and Maciel, M. (2009) Control de Phlebotomine (Diptera: Psychodidae) Leishmaniasis Vectors. Neotropical Entomology, 38, 303-310. http://dx.doi.org/10.1590/S1519-566X2009000300001</mixed-citation></ref><ref id="scirp.70318-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Vivero, R., Torres-Gutierrez, C., Bejarano, E., Cadena, H., Estrada, L., Florez, F., et al. (2015) Study on Natural Breeding Sites of Sand Flies (Diptera: Phlebotominae) in Areas of Leishmania Transmission in Colombia. Parasit and Vectors, 8, 116.  
http://dx.doi.org/10.1186/s13071-015-0711-y</mixed-citation></ref><ref id="scirp.70318-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Freitas-Junior, L., Chatelain, L., Andrade, H. and Siqueira-Neto, J. (2012) Visceral Leishmaniasis Treatment: What Do We Have, What Do We Need and How To Deliver It? International Journal for Parasitology: Drugs and Drug Resistance, 2, 11-19. 
http://dx.doi.org/10.1016/j.ijpddr.2012.01.003</mixed-citation></ref><ref id="scirp.70318-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Lemos. P., Dantas-Torresa, F., da Silva, F., Veloso, V., Gaudêncioa, K. and Brandao-Filhoa, S. (2013) Ecology of Lutzomyia longipalpis in an Area of Visceral Leishmaniasis Transmission in North-Eastern Brazil. Acta Tropica, 126, 99-102.  
http://dx.doi.org/10.1016/j.actatropica.2013.01.011</mixed-citation></ref><ref id="scirp.70318-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Montoya-Lerma, J., Cadena, H., Oviedo, M., Ready, P., Barazarte, R., Travi, B. and Lane, R. (2003) Comparative Vectorial Efficiency of Lutzomyia evansi and Lu. longipalpis for Transmitting Leishmania chagasi. Acta Tropica, 85, 19-29.  
http://dx.doi.org/10.1016/S0001-706X(02)00189-4</mixed-citation></ref><ref id="scirp.70318-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Rangel, E. and Vilela, M. (2008) Lutzomyia longipalpis (Diptera, Psychodidae, Phlebotominae) and Urbanization of Visceral Leishmaniasis in Brazil. Cadernos de Saúde Pública, 24, 2948-2952. http://dx.doi.org/10.1590/S0102-311X2008001200025</mixed-citation></ref><ref id="scirp.70318-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Desjeux, P. (2004) Leishmaniasis: Current Situation and New Perspectives. Comparative Immunology, Microbiology &amp; Infectious Diseases, 27, 305-318.  
http://dx.doi.org/10.1016/j.cimid.2004.03.004</mixed-citation></ref><ref id="scirp.70318-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Raffa, K., Adams, A., Broderick, N., Boone, C., Cardoza, Y., Delalibera, I. and Vasanthakumar, A. (2008) Symbionts of Invasive Insects: Characterization, Ecological Roles, and Relation to Invasive Potential and Management Strategies. Department of Entomology, University of Wisconsin-Madison, Madison, 61-62.</mixed-citation></ref><ref id="scirp.70318-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Shanchez-Contreras, M. and Vlisidou, I. (2008) The Diversity of Insect-Bacteria Interactions and Its Applications for Disease Control. Biotechnology and Genetic Engineering, 25, 203-244. http://dx.doi.org/10.5661/bger-25-203</mixed-citation></ref><ref id="scirp.70318-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Azambuja, P., Garcia, E. and Ratcliffe, N. (2005) Gut Microbiota and Parasite Transmission by Insect Vectors. Trends in Parasitology, 21, 568-572.  
http://dx.doi.org/10.1016/j.pt.2005.09.011</mixed-citation></ref><ref id="scirp.70318-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Sant’anna, M., Darby, A., Brazil, R., Montoya, J., Dillon, V., et al. (2012) Investigation of the Bacterial Communities Associated with Females of Lutzomyia Sand Fly Species from South America. PLoS ONE, 7, e42531. http://dx.doi.org/10.1371/journal.pone.0042531</mixed-citation></ref><ref id="scirp.70318-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Moraes, A., Sergio, H., et al. (2008) Leishmania (Leishmania) chagasi Interactions with Serratia marcescens: Ultrastructural Studies, Lysis and Carbohydrate Effects. Experimental Parasitology, 118, 561-568. http://dx.doi.org/10.1016/j.exppara.2007.11.015</mixed-citation></ref><ref id="scirp.70318-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Boulanger, N., Lowenberger, C., Volf, P., et al. (2004) Characterization of a Defensin from the Sand Fly Phlebotomus duboscqi Induced by Challenge with Bacteria or the Protozoan Parasite Leishmania major. Infection and Immunity, 72, 7140-7146. 
http://dx.doi.org/10.1128/IAI.72.12.7140-7146.2004</mixed-citation></ref><ref id="scirp.70318-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Días, H., Sant’anna, M. and Genta, F. (2012) Reactive Oxygen Species-Mediated Immunity against Leishmania mexicana and Serratia marcescens in the Phlebotomine Sand Fly Lutzomyia longipalpis. The Journal of Biological Chemistry, 287, 23995-24003.  
http://dx.doi.org/10.1074/jbc.M112.376095</mixed-citation></ref><ref id="scirp.70318-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Sant’Anna, M., Diaz-Albiter, H., Aguiar, K., et al. (2014) Colonisation Resistance in the Sand Fly Gut: Leishmania Protects Lutzomyia longipalpis from Bacterial Infection. Parasites &amp; Vectors, 7, 329. http://dx.doi.org/10.1186/1756-3305-7-329</mixed-citation></ref><ref id="scirp.70318-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">González, C., Cabrera, O., Munstermann, L. and Ferro, C. (2006) Distribución de los vectores de Leishmania infantum (Kinetoplastida: Trypanosomatidae) en Colombia. Biomédica, 26, 64-72. http://dx.doi.org/10.7705/biomedica.v26i1.1501</mixed-citation></ref><ref id="scirp.70318-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Vivero, R., Torres-Gutierrez, C., Bejarano, E., Estrada, L., Florez, F., et al. (2009) Nuevos registros de flebotomíneos (Diptera: Psychodidae), con el hallazgo de Lutzomyia longipalpis (Lutz &amp; Neiva, 1912), en los alrededores de la Ciudad de Sincelejo, Colombia. Biota Neotropica, 9, 277-280. http://dx.doi.org/10.1590/S1676-06032009000400031</mixed-citation></ref><ref id="scirp.70318-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Pulido, S., Munoz, D., Restrepo, A., Mesa, C., Alzate, J., Vélez, I. and Robledo, S. (2011) Improvement of the Green Fluorescent Protein Reporter System in Leishmania spp. for the in Vitro and in Vivo Screening of Antileishmanial Drugs. Acta Tropica, 122, 36-45.  
http://dx.doi.org/10.1016/j.actatropica.2011.11.015</mixed-citation></ref><ref id="scirp.70318-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Romero-Tabarez, M., Jansen, R., Sylla, M., Lünsdorf, H., Haussler, S., Santosa, D., et al. (2006) 7-O-Malonyl Macrolactin A, a New Macrolactin Antibiotic from Bacillus subtilis Active against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci, and a Small-Colony Variant of Burkholderia cepacia. Antimicrobial Agents and Chemotherapy, 50, 1701-1709. http://dx.doi.org/10.1128/AAC.50.5.1701-1709.2006</mixed-citation></ref><ref id="scirp.70318-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Krug, D., Zurek, G., Revermann, O., Vos, M., Velicer, G. and Müller, R. (2008) Discovering the Hidden Secondary Metabolome of Myxococcus xanthus: A Study of Intraspecific Diversity. Applied and Environmental Microbiology, 74, 3058-3068.  
http://dx.doi.org/10.1128/AEM.02863-07</mixed-citation></ref><ref id="scirp.70318-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Sierra-Garcia, I., Romero, M. and Orduz, S. (2012) Determinación de la actividad antimicrobiana e insecticida de extractos producidos por bacterias aisladas de suelo. Actualidades Biológicas, 34, 5-19.</mixed-citation></ref><ref id="scirp.70318-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Sangnoi, Y., Srisukchayakul, P., Arunpairojana, V. and Kanjana-Opas, A. (2009) Diversity of Marine Gliding Bacteria in Thailand and Their Cytotoxicity. Electronic Journal of Biotechnology, 12, 1-8.</mixed-citation></ref><ref id="scirp.70318-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">El-Masry, H., Fahmy, H. and Abdelwahed, A. (2000) Synthesis and Antimicrobial Activity of Some New Benzimidazole Derivatives. Molecules, 5, 1429-1438.  
http://dx.doi.org/10.3390/51201429</mixed-citation></ref><ref id="scirp.70318-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Cona, E. (2002) Condiciones para un buen estudio de susceptibilidad mediante test de difusión en agar. Revista Chilena de Infectología, 19, 77-81.  
http://dx.doi.org/10.4067/S0716-10182002019200001</mixed-citation></ref><ref id="scirp.70318-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Clinical and Laboratory Standards Institute—CLSI (2009) Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically. Approved Standard, 29, 1-65.</mixed-citation></ref><ref id="scirp.70318-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Maleki-Ravasan, M., Oshaghi, M., Afshar, D., et al. (2015) Aerobic Bacterial Flora of Biotic and Abiotic Compartments of a Hyperendemic Zoonotic Cutaneous Leishmaniasis (ZCL) Focus. Parasites &amp; Vectors, 8, 63. http://dx.doi.org/10.1186/s13071-014-0517-3</mixed-citation></ref><ref id="scirp.70318-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Cox, C.R., Coburn, P.S. and Gilmore, M.S. (2005) Enterococcal Cytolysin: A Novel Two Component Peptide System That Serves as a Bacterial Defense against Eukaryotic and Prokaryotic Cells. Current Protein &amp; Peptide Science, 6, 77-84.  
http://dx.doi.org/10.2174/1389203053027557</mixed-citation></ref><ref id="scirp.70318-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Sacks, D., Govind, M., Rowton, E., Spa, G., Epstein, L., Turcoi, S. and Beverley, S. (2000) The Role of Phosphoglycans in Leishmania-Sand Fly Interactions. Proceedings of the National Academy of Sciences of the United States of America, 97, 406-411.  
http://dx.doi.org/10.1073/pnas.97.1.406</mixed-citation></ref><ref id="scirp.70318-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Kamhawi, S. (2006) Phlebotomine Sand Flies and Leishmania Parasites: Friends or Foes? Trends in Parasitology, 22, 439-445. http://dx.doi.org/10.1016/j.pt.2006.06.012</mixed-citation></ref><ref id="scirp.70318-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Yadav, K., Bora, A., Datta, S., et al. (2015) Molecular Characterization of Midgut Microbiota of Aedes albopictus and Aedes aegypti from Arunachal Pradesh, India. Parasites &amp; Vectors, 8, 641. http://dx.doi.org/10.1186/s13071-015-1252-0</mixed-citation></ref><ref id="scirp.70318-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Akhoundi, M., Bakhtiari, R., Guillard, T., Baghaei, A., Tolouei, R., Sereno, D., et al. (2012) Diversity of the Bacterial and Fungal Microflora from the Midgut and Cuticle of Phlebotomine Sand Flies Collected in North-Western Iran. PLoS ONE, 7, e50259.  
http://dx.doi.org/10.1371/journal.pone.0050259</mixed-citation></ref><ref id="scirp.70318-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Bonaterra, A., Badosa, E., Rezzonico, F., Duffy, B. and Montesinos, E. (2014) Phenotypic Comparison of Clinical and Plant-Beneficial Strains of Pantoea agglomerans. International Microbiology, 17, 81-90.</mixed-citation></ref><ref id="scirp.70318-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Maayer, D., Chan, W., Rubagotti, E., Venter, E., Toth, I., Birch, P. and Coutinho, C. (2014) Analysis of the Pantoea ananatis Pan-Genome Reveals Factors Underlying Its Ability to Colonize and Interact with Plant, Insect and Vertebrate Hosts. BMC Genomics, 15, 404.  
http://www.biomedcentral.com/1471-2164/15/404</mixed-citation></ref><ref id="scirp.70318-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Bisi, D. and Lampe, D. (2011) Secretion of Anti-Plasmodium Effector Proteins from a Natural Pantoea agglomerans Isolated by Using PelB and HlyA Secretion Signals. Applied and Environmental Microbiology, 77, 4669-4675. http://dx.doi.org/10.1128/AEM.00514-11</mixed-citation></ref><ref id="scirp.70318-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Volf, P., Kiewegová, A. and Nemec, A. (2002) Bacterial Colonisation in the Gut of Phlebotomus dubosqi (Diptera: Psychodidae): Transtadial Passage and the Role of Female Diet. Folia Parasitologica, 49, 73-77. http://dx.doi.org/10.14411/fp.2002.014</mixed-citation></ref><ref id="scirp.70318-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Vallet-Gely, I., Lemaitre, B. and Boccard, F. (2008) Bacterial Strategies to Overcome Insect Defences. Nature, 6, 302-313. http://dx.doi.org/10.1038/nrmicro1870</mixed-citation></ref><ref id="scirp.70318-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Shyntum, D., Theron, J., Venter, S., Moleleki, L., Toth, I. and Coutinho, T. (2015) Pantoea ananatis Utilizes a Type VI Secretion System for Pathogenesis and Bacterial Competition. Molecular Plant-Microbe Interactions, 28, 420-431.  
http://dx.doi.org/10.1094/MPMI-07-14-0219-R</mixed-citation></ref><ref id="scirp.70318-ref39"><label>39</label><mixed-citation publication-type="book" xlink:type="simple">Holland, B. (2010) The Extraordinary Diversity of Bacterial Protein Secretion Mechanisms. In: Economou, A., Ed., Protein Secretion Methods and Protocols, Humana Press, New York, 1-20. http://dx.doi.org/10.1007/978-1-60327-412-8_1</mixed-citation></ref><ref id="scirp.70318-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Riley, M., Goldtone, C., Wertz, J. and Gordon, D. (2003) A Phylogenetic Approach to Assessing the Targets of Microbial Warfare. Journal of Evolutionary Biology, 16, 690-697.  
http://dx.doi.org/10.1046/j.1420-9101.2003.00575.x</mixed-citation></ref><ref id="scirp.70318-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Mandal, S., Sharma, S., Pinnaka, K., Kumari, A. and Korpole, S. (2013) Isolation and Characterization of Diverse Antimicrobial Lipopeptides Produced by Citrobacter and Enterobacter. BMC Microbiology, 13, 152. http://dx.doi.org/10.1186/1471-2180-13-152</mixed-citation></ref><ref id="scirp.70318-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Seleem, M., Ali, M., Boyle, S., et al. (2006) Establishment of a Gene Expression System in Ochrobactrum anthropi. Applied and Environmental Microbiology, 72, 6833-6836.  
http://dx.doi.org/10.1128/AEM.01446-06</mixed-citation></ref><ref id="scirp.70318-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Bergman, J. (2003) Does the Acquisition of Antibiotic and Pesticide Resistance Provide Evidence for Evolution? Journal of Creation, 17, 26-32.</mixed-citation></ref><ref id="scirp.70318-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Ogawa, J., Takeda, S., Xie, S., et al. (2001) Purification, Characterization, and Gene Cloning of Purine Nucleosidase from Ochrobactrum anthropi. Applied and Environmental Microbiology, 67, 1783-1787. http://dx.doi.org/10.1128/AEM.67.4.1783-1787.2001</mixed-citation></ref><ref id="scirp.70318-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Tamburro, A., Robuffo, I., Heipieper, H., et al. (2004) Expression of Glutathione S-Transferase and Peptide Methionine Sulphoxide Reductase in Ochrobactrum anthropi Is Correlated to the Production of Reactive Oxygen Species Caused by Aromatic Substrates. FEMS Microbiology Letters, 241, 151-156. http://dx.doi.org/10.1016/j.femsle.2004.10.013</mixed-citation></ref><ref id="scirp.70318-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Higgins, C., Murtough, S., Williamson, E., Hiom, S. and Payne, D. (2001) Biocides among Non-Fermenting Gram-Negative Bacteria. Clinical Microbiology and Infection, 7, 308-315.  
http://dx.doi.org/10.1046/j.1198-743x.2001.00253.x</mixed-citation></ref><ref id="scirp.70318-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Vay, C., Almuzara, M., Rodríguez, C., Pugliese, M., Barba, F., Mattera, J. and Famiglietti, A. (2005) Actividad “in Vitro” de diferentes antibacterianos sobre bacilos gram-negativos no fermentadores, excluidos Pseudomonas aeruginosa y Acinetobacter spp. Revista Argentina de Microbiología, 37, 34-45.</mixed-citation></ref><ref id="scirp.70318-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Nadjar, D., Labia, R., Cerceau, C., Bizet, C., Philippon, A. and Arlet, G. (2001) Molecular Characterization of Chromosomal Class C β-Lactamase and Its Regulatory Gene in Ochrobactrum anthropi. Antimicrobial Agents and Chemotherapy, 45, 2324-2330.  
http://dx.doi.org/10.1128/AAC.45.8.2324-2330.2001</mixed-citation></ref><ref id="scirp.70318-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Duran, R., Vatansever, U., Acunas, B. and Basaran, U. (2009) Ochrobactrum anthropi Bacteremia in a Preterm Infant with Meconium Peritonitis. International Journal of Infectious Diseases, 2, 61-63. http://dx.doi.org/10.1016/j.ijid.2008.06.027</mixed-citation></ref><ref id="scirp.70318-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Fernández-Fuentes, M., Morente, E., Abriouel, H., Pulido, R. and Gálvez, A. (2012) Isolation and Identification of Bacteria from Organic Foods: Susceptibility to Biocides and Antibiotics. Food Control, 26, 73-78. http://dx.doi.org/10.1016/j.foodcont.2012.01.017</mixed-citation></ref></ref-list></back></article>